RNA Law
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
RNA Law, established in June 2024, is a specialised IP boutique with a strong focus on the life sciences and pharmaceutical sectors. The firm has deep expertise in acting for life sciences clients in patent validity and invalidity cases, patent term adjustments, enforcement litigation, and transactional patent work. The practice also covers regulatory matters involving ANVISA and other authorities, as well as technology transfer agreements and R&D projects. The team is jointly led by IP litigators Rob Rodrigues and Tatiana Alves, alongside IP protection and technology transfer specialist Karlo Tinoco, regulatory expert Brenno Telles, and Ciro Albuquerque, who focuses on patent infringement and invalidity disputes.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The firm stands out for its in-depth knowledge of the industry and its strategic and personalised approach, ensuring effective solutions with high added value. It has a highly technical and specialised team. RNA Law also stands out for its experience in complex disputes, with an excellent rate of favourable results. In addition, the team and partners are very agile and co-operative.’
- ‘Rob Rodrigues does a great job understanding commercial needs aligned with patent strategy. He is a great communicator, responsive, and I trust him with high-value matters.’
Key clients
- Inserm
- Onxeo
Work highlights
Represented Intervet (MSD Animal Health) in an invalidity lawsuit filed by Ourofino against Intervet’s patent covering Bravecto®.